Naveen Pemmaraju, Professor in the Department of Leukemia at UT MD Anderson Cancer Center, shared a post X:
“Very proud to share our brand new article just out in Leukemia Journal led by own brilliant colleague Dr Hannah Beird.
Novel finding in our BPDCN field decreased TXNRD1 associated with tagraxofusp resistance in BPDCN.”
Title: Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II
Authors: Hannah C. Beird, Sankaranarayanan Kannan, Jingjing Liu, Janice Chen, Arturo Olguin, Poonam Desai, Tianyu Cai, Lina Han, Jennifer L. Cotton, Sandeep Singh, Saurabh Kumar Gupta, Latasha Little, Marcos R. Estecio, Xingzhi Song, Hussein A. Abbas, Jianhua Zhang, Curtis Gumbs, Christopher Brooks, Hagop Kantarjian, Michael Andreeff, Marina Konopleva, P. Andrew Futreal, Naveen Pemmaraju
Other articles featuring Naveen Pemmaraju on OncoDaily.